{"id":"W1971737397","doi":"10.1111/j.1582-4934.2009.00991.x","title":"Clinical outcomes in non‐small‐cell lung cancer patients with <i>EGFR</i> mutations: pooled analysis","year":2010,"lang":"en","type":"review","venue":"Journal of Cellular and Molecular Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Eisai; F. Hoffmann-La Roche; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Gefitinib; Erlotinib; Lung cancer; Oncology; Medicine; Internal medicine; Epidermal growth factor receptor; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004914161,0.0004378005,0.003396088,0.0009661238,0.00004731794,0.00001764311,0.0001448262,0.0003170274,0.00007442614],"category_scores_gemma":[0.0001214413,0.0002405703,0.0007823175,0.0007820723,0.0001418983,0.00005814396,0.00002800217,0.001010848,0.000001110287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001462099,"about_ca_system_score_gemma":0.0007575047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009659803,"about_ca_topic_score_gemma":0.00005762143,"domain_scores_codex":[0.9970465,0.0001479766,0.001644506,0.0003432206,0.0005631854,0.0002546146],"domain_scores_gemma":[0.9973674,0.0001940325,0.001298287,0.0003211626,0.0004380086,0.000381148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0002279892,0.002857913,0.3801429,0.01192179,0.03659566,0.00377843,0.0008168728,0.00002456159,0.00008111,0.00001951586,0.0003539772,0.5631793],"study_design_scores_gemma":[0.02898908,0.003380642,0.04268703,0.03007435,0.5105062,0.0001405883,0.000186757,0.0000601984,0.00003034688,0.00002070859,0.3829646,0.0009595269],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02189361,0.9744529,0.00160914,0.0002678031,0.0003681766,0.001056805,0.0000245289,0.000005914872,0.0003211444],"genre_scores_gemma":[0.01058725,0.9871011,0.0009142397,0.0004400882,0.0002262591,0.00004897247,0.0002665513,0.00006469117,0.0003508363],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5622198,"threshold_uncertainty_score":0.981017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01356794701440404,"score_gpt":0.368742977523374,"score_spread":0.3551750305089699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}